This tag is created dynamically through created issue pages
In comments submitted today, FAH reiterated its full support for CMS’s prospective budget-neutral 340B payment policy to continue to pay Average Sales Price (ASP) minus 22.5 percent for 340B-acquired drugs. “We agree with CMS that […]
Read More… from FAH Comments on CY 2022 Medicare OPPS Proposed Rule
Today, FAH submitted comments to CMS on the CY 2022 Physician Fee Schedule Proposed Rule. The rule, which affects payments beginning January 1, 2022, encompasses several proposals important to FAH members. FAH offered several recommendations […]
Read More… from FAH Submits Comments on 2022 Physician Payment Proposed Rule
